Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Molecular Pathways

Molecular Pathways: The Complex Roles of Inflammation Pathways in the Development and Treatment of Liver Cancer

Kostas Nikolaou, Michalis Sarris and Iannis Talianidis
Kostas Nikolaou
Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michalis Sarris
Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iannis Talianidis
Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-12-1961 Published June 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Regulation of cell death and proliferation by the NF-κB and JNK pathways. Complexes assembled on ligand-bound TNF or TLR and IL-1 receptors mediate TAK1 activation, whose activity is modulated by Cyld. TAK1 phosphorylates IKK-β, which in turn phosphorylates IκB, leading to its ubiquitin-proteosome–mediated degradation and release of NF-κB (p50–p65) factors, which translocate to the nucleus to activate the transcription of prosurvival genes. NF-κB also induces the expression of cFLIP and SOD2, which inhibit apoptosis and reactive oxygen species (ROS) accumulation. TAK1 also phosphorylates MKK4/7, which activates JNK1/2. Short-term JNK activation induces the expression of genes involved in proliferation control, via the phosphorylation-mediated activation of JUN transcription factors. Sustained JNK activation induces the expression of proapoptotic genes, and stabilizes p53 and the Bax/Bak-dependent apoptotic pathway. NF-κB feedback regulates its own activation via modulating Cyld expression and the activation of JNK via activating Gadd45β expression, which inhibits MKK4/7. JNK activation is also modulated by ROS accumulation through dual-specificity phosphatase 1 (DUSP1) phosphatase activity. CASP-3/8, caspase-3/8.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Mechanism of cell death–mediated inflammation, fibrosis, and carcinogenesis. Sustained JNK activation causes hepatocyte death. Dying hepatocytes release alarmins/damage-associated molecular patterns (DAMP), which leads to the recruitment of Kupffer cells. NF-κB pathway activation in Kupffer cells leads to the expression and secretion of TGF-β, TNF-α, and IL-6 cytokines. TGF-β activates hepatic stellate cells, resulting in fibrogenesis. TNF-α induces apoptosis in the neighboring hepatocytes. Hepatocytes that escape or do not complete cell death may respond to IL-6 via activation of STAT3, which induces compensatory hepatocyte proliferation. IL-6R, IL-6 receptor.

PreviousNext
Back to top
Clinical Cancer Research: 19 (11)
June 2013
Volume 19, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Pathways: The Complex Roles of Inflammation Pathways in the Development and Treatment of Liver Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Molecular Pathways: The Complex Roles of Inflammation Pathways in the Development and Treatment of Liver Cancer
Kostas Nikolaou, Michalis Sarris and Iannis Talianidis
Clin Cancer Res June 1 2013 (19) (11) 2810-2816; DOI: 10.1158/1078-0432.CCR-12-1961

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecular Pathways: The Complex Roles of Inflammation Pathways in the Development and Treatment of Liver Cancer
Kostas Nikolaou, Michalis Sarris and Iannis Talianidis
Clin Cancer Res June 1 2013 (19) (11) 2810-2816; DOI: 10.1158/1078-0432.CCR-12-1961
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Clinical–Translational Advances
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Targeting of the Liver Microenvironment
  • Targeting the Protein Kinase Wee1 in Cancer
  • Metabolic Control of Histone Methylation and Gene Expression
Show more Molecular Pathways
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement